Latest Pharma and Biotech News
Pharmaceutical
8 January 2025 Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related diseases, has announced a setback.
Today's issue
Refine Search
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Biotechnology
Spanish firm Grifols has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US Food and Drug Administration (FDA). 9 January 2025
Biotechnology
German family-owned pharma major Boehringer Ingelheim has licensed antibody-drug conjugates ADC technology from Netherlands-based Synaffix, a Lonza company. 9 January 2025
Biotechnology
Shares in French food allergy biotech DBV Technologies looked set to close more than 10% higher on Thursday. 9 January 2025
Pharmaceutical
German pharma major Bayer today announced top-line results of the Phase III study OASIS 4 investigating elinzanetant as non-hormonal treatment for moderate to severe vasomotor symptoms caused by adjuvant endocrine therapy in women with hormone receptor positive breast cancer or in women at high risk of developing breast cancer. 9 January 2025
Biotechnology
UK-based biotech MitoRx Therapeutics has bolstered its leadership team with the appointment of Lubor Gaal as chief business officer and Stacey Massey as finance director. 9 January 2025
Biotechnology
Sanofi has announced promising results from its Phase III IRAKLIA study, which tested a subcutaneous version of Sarclisa (isatuximab) in combination with chemo, in multiple myeloma. 9 January 2025
Pharmaceutical
Intelligence provider Clarivate has released the 12th annual Drugs to Watch report, a guide to the therapies poised to redefine the future of healthcare. 9 January 2025
Biotechnology
Swiss oncology-focused Araris Biotech developing next-generation antibody drug conjugates (ADCs), today announced a research collaboration and option to license agreement (RCO) with Japan’s Chugai Pharmaceutical. 9 January 2025
Biotechnology
UK-based Alchemab Therapeutics, a biopharma seeking to identify and develop naturally occurring therapeutic antibodies from resilient individuals, has entered a collaboration with US pharma major Eli Lilly to discover novel therapeutic candidates to treat amyotrophic lateral sclerosis (ALS). 9 January 2025
Pharmaceutical
UK headquartered Verdiva Bio Limited today announced its launch as a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders. 9 January 2025
Pharmaceutical
Italy-based Newron Pharmaceuticals (SIX: NWRN, XETRA: NP5), a biopharma developing therapies for diseases of the central and peripheral nervous system, has announced a deal with South Korea’s Myung In Pharm. 9 January 2025
Biotechnology
Cambridge, USA-based biotech Sunbird Bio, which is developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced the appointment of DR Richard Batrla, as chief medical officer. 9 January 2025
Pharmaceutical
British pharma major AstraZeneca has received positive news from the reimbursement from the UK’s health technology assessor. 9 January 2025
Pharmaceutical
German family-owned pain focused drugmaker Grünenthal announced today that Prof Dr Uli Brödl will assume the role of chief scientific officer (CSO) and a member of the corporate executive board, effective February 1, 2025. 9 January 2025
Biotechnology
MaaT Pharma saw its shares rise by nearly 20% in early trading Thursday, following the announcement of positive topline results from a Phase III trial of its microbiome-based therapy, MaaT013. 9 January 2025
Biotechnology
AiCuris has appointed Jacques Dumas, formerly chief scientific officer at Arrakis Therapeutics, into the CSO role. 8 January 2025
Biotechnology
Canadian biotech Aspect Biosystems, which is developing bioprinted tissue therapeutics as a new category in regenerative medicine, has closed a $115 million Series B financing round. 8 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related diseases, has announced a setback. 8 January 2025
All news
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Biotechnology
Spanish firm Grifols has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US Food and Drug Administration (FDA). 9 January 2025
Biotechnology
German family-owned pharma major Boehringer Ingelheim has licensed antibody-drug conjugates ADC technology from Netherlands-based Synaffix, a Lonza company. 9 January 2025
Biotechnology
Shares in French food allergy biotech DBV Technologies looked set to close more than 10% higher on Thursday. 9 January 2025
Pharmaceutical
German pharma major Bayer today announced top-line results of the Phase III study OASIS 4 investigating elinzanetant as non-hormonal treatment for moderate to severe vasomotor symptoms caused by adjuvant endocrine therapy in women with hormone receptor positive breast cancer or in women at high risk of developing breast cancer. 9 January 2025
Biotechnology
UK-based biotech MitoRx Therapeutics has bolstered its leadership team with the appointment of Lubor Gaal as chief business officer and Stacey Massey as finance director. 9 January 2025
Biotechnology
Sanofi has announced promising results from its Phase III IRAKLIA study, which tested a subcutaneous version of Sarclisa (isatuximab) in combination with chemo, in multiple myeloma. 9 January 2025
Pharmaceutical
Intelligence provider Clarivate has released the 12th annual Drugs to Watch report, a guide to the therapies poised to redefine the future of healthcare. 9 January 2025
Biotechnology
Swiss oncology-focused Araris Biotech developing next-generation antibody drug conjugates (ADCs), today announced a research collaboration and option to license agreement (RCO) with Japan’s Chugai Pharmaceutical. 9 January 2025
Biotechnology
UK-based Alchemab Therapeutics, a biopharma seeking to identify and develop naturally occurring therapeutic antibodies from resilient individuals, has entered a collaboration with US pharma major Eli Lilly to discover novel therapeutic candidates to treat amyotrophic lateral sclerosis (ALS). 9 January 2025
Pharmaceutical
UK headquartered Verdiva Bio Limited today announced its launch as a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders. 9 January 2025
Pharmaceutical
Italy-based Newron Pharmaceuticals (SIX: NWRN, XETRA: NP5), a biopharma developing therapies for diseases of the central and peripheral nervous system, has announced a deal with South Korea’s Myung In Pharm. 9 January 2025
Biotechnology
Cambridge, USA-based biotech Sunbird Bio, which is developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced the appointment of DR Richard Batrla, as chief medical officer. 9 January 2025
Pharmaceutical
British pharma major AstraZeneca has received positive news from the reimbursement from the UK’s health technology assessor. 9 January 2025
Pharmaceutical
German family-owned pain focused drugmaker Grünenthal announced today that Prof Dr Uli Brödl will assume the role of chief scientific officer (CSO) and a member of the corporate executive board, effective February 1, 2025. 9 January 2025
Biotechnology
MaaT Pharma saw its shares rise by nearly 20% in early trading Thursday, following the announcement of positive topline results from a Phase III trial of its microbiome-based therapy, MaaT013. 9 January 2025
Biotechnology
AiCuris has appointed Jacques Dumas, formerly chief scientific officer at Arrakis Therapeutics, into the CSO role. 8 January 2025
Biotechnology
Canadian biotech Aspect Biosystems, which is developing bioprinted tissue therapeutics as a new category in regenerative medicine, has closed a $115 million Series B financing round. 8 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related diseases, has announced a setback. 8 January 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze